← Back to Search

Local Anesthetic

1 for Overactive Bladder

Phase 3
Waitlist Available
Led By Frank F. Tu, MD, MPH
Research Sponsored by Frank Tu
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Summary

The purpose of this study is to determine whether alkalized lidocaine instilled into the bladder is effective in the treatment of overactive bladder (OAB).

Eligible Conditions
  • Overactive Bladder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Average Weekly NRS for Frequency at 6 Weeks
Cystometric Assessment of Maximal Bladder Capacity at 6 Weeks Only.
Global Assessment of Change - Frequency at 6 Weeks
+2 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: 1Active Control1 Intervention
xylocaine
Group II: 2Placebo Group1 Intervention
normal saline

Find a Location

Who is running the clinical trial?

Berlex FoundationOTHER
1 Previous Clinical Trials
25 Total Patients Enrolled
Frank TuLead Sponsor
Frank F. Tu, MD, MPHPrincipal InvestigatorNorthShore University HealthSystem
~1 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top